James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
The study (BOOST-3) is sponsored by the National Institutes of Health, and compares two treatments routinely used for monitoring patients with severe TBI in the Neuroscience Intensive Care Unit.
We are pleased to introduce our incoming adult and child neurology residents as well as our fellows specializing in sleep medicine and neuromuscular disorders. Our new team members will begin this summer.
The UNC Comprehensive Stroke Center is excited to announce its second annual Stroke Survivor & Caregiver Event! The event will be held on March 7, 2020, at the Carolina Inn in Chapel Hill, NC. This event allows an opportunity for fellowship among stroke survivors, their caregivers and health care professionals, and also provides an opportunity … Continued
The NICU received an inaugural UNC Medical Center Quality & Safety Award on Jan 14
Dr. Browner is the Department of Neurology’s vice chair for education and the director of the Adult Neurology Residency Program.
This symposium on November 1, 2019, will provide an opportunity for continuing education for EMS & critical care transport providers on emergency neurologic and cardiac care.